Dr. Nasrazadani (Dr. Ozy) shared her career journey from biochemistry to clinical oncology at MD Anderson, where she focuses on inflammatory breast cancer research and treatment. Terry and Dr. Ozy discussed the challenges of academic research, including financial struggles and the need to balance clinical obligations with research efforts. They explored the progress and future directions in IBC research, emphasizing the importance of patient involvement in studies and advocacy initiatives, including the MD Anderson Boot Walk.